Hellström PM (2013) Satiety signals and obesity. Curr Opin Gastroenterol 29:222–227PubMedCrossRef

Hira T, Mochida T, Miyashita K et al (2009) GLP-1 secretion is enhanced directly in the ileum but indirectly in the duodenum by a newly identified potent stimulator, zein hydrolysate, in rats. Am J Physiol Gastrointest Liver Physiol 297:G663–G671PubMedCrossRef

Irwin N, Flatt PR (2013) Enteroendocrine hormone mimetics for the treatment of obesity and diabetes. Curr Opin Pharmacol 13:989–995PubMedCrossRef

Irwin N, Frizelle P, Montgomery IA et al (2012) Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetes. Diabetologia 55:2747–2758PubMedCrossRef

Jordi J, Herzog B, Camargo SM et al (2013) Specific amino acids inhibit food intake via the area postrema or vagal afferents. J Physiol 591:5611–5621PubMedCentralPubMedCrossRef

Kaiyala KJ, Prigeon RL, Kahn SE et al (2000) Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes 49:1525–1533PubMedCrossRef

Karra E, Batterham RL (2010) The role of gut hormones in the regulation of body weight and energy homeostasis. Mol Cell Endocrinol 316:120–128PubMedCrossRef

Koda S, Date Y, Murakami N et al (2005) The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology 146:2369–2375PubMedCrossRef

Kohno D, Yada T (2012) Arcuate NPY neurons sense and integrate peripheral metabolic signals to control feeding. Neuropeptides 46:315–319PubMedCrossRef

Kojima M, Hosoda H, Date Y et al (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656–660PubMedCrossRef

Kuhre RE, Gribble FM, Hartmann B et al (2014) Fructose stimulates GLP-1 but not GIP secretion in mice, rats, and humans. Am J Physiol Gastrointest Liver Physiol 306:G622–G630PubMedCentralPubMedCrossRef

le Roux CW, Neary NM, Halsey TJ et al (2005) Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab 90:4521–4524PubMedCrossRef

le Roux CW, Batterham RL, Aylwin SJ et al (2006) Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 147:3–8PubMedCrossRef

Lechin F, Dijs B, Pardey-Maldonado B (2013) Insulin versus glucagon crosstalk: central plus peripheral mechanisms. Am J Ther 20:349–362PubMedCrossRef

Lowe MR, Butryn ML (2007) Hedonic hunger: a new dimension of appetite? Physiol Behav 91:432–439PubMedCrossRef

Martínez de Morentin PB, Martinez-Sanchez N, Roa J et al (2014) Hypothalamic mTOR: the rookie energy sensor. Curr Mol Med 14:3–21PubMedCrossRef

McIntyre RS, Powell AM, Kaidanovich-Beilin O et al (2013) The neuroprotective effects of GLP-1: possible treatments for cognitive deficits in individuals with mood disorders. Behav Brain Res 237:164–171PubMedCrossRef

Mentlein R, Gallwitz B, Schmidt WE (1993) Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem 214:829–835PubMedCrossRef